Department of Oncological Sciences, Mount Sinai School of Medicine, USA.
J Consult Clin Psychol. 2011 Feb;79(1):64-74. doi: 10.1037/a0022199.
Hematopoietic stem cell transplant (HSCT) survivors who are 1 to 3 years posttransplant are challenged by the need to resume valued social roles and activities--a task that may be complicated by enduring transplant-related psychological distress common in this patient population. The present study investigated whether transplant survivors who receive adequate social support from their spouse or intimate partner experience lower distress.
Effects of receiving a greater quantity of partner support (a common approach to studying enacted support) were compared with effects of receiving more effective partner support (i.e., support that more closely matches their needs in terms of its quantity and quality). Men and women (N = 230) who were 1 to 3 years posttransplant completed measures of partner support quantity (Manne & Schnoll, 2001), partner social support effectiveness (Rini & Dunkel Schetter, 2010), and psychological distress (Brief Symptom Inventory; Derogatis & Spencer, 1982). Potential medical and sociodemographic confounds were controlled in analyses.
As hypothesized, survivors reported less distress when they received more effective partner support (p < .001). Quantity of partner support was not associated with distress (p = .23). An interaction revealed that when partner support was effective, the quantity of support survivors received was not associated with their distress (p = .90); however, when partner support was ineffective, receiving a greater quantity of partner support was associated with substantially elevated distress (p = .002).
Findings suggest that clinical approaches to addressing or preventing enduring distress after HSCT should target features of partner support related to its appraised effectiveness.
造血干细胞移植（HSCT）后 1 至 3 年的患者需要恢复有价值的社会角色和活动，但他们可能会因该患者群体中常见的持久移植相关心理困扰而感到困难。本研究调查了配偶或亲密伴侣提供足够社会支持的移植幸存者是否会感到较低的困扰。
比较了接受更多伴侣支持（研究实施支持的常见方法）的效果与接受更有效的伴侣支持（即支持在数量和质量上更符合他们需求的支持）的效果。1 至 3 年移植后的男性和女性（N=230）完成了伴侣支持数量量表（Manne & Schnoll，2001）、伴侣社会支持有效性量表（Rini & Dunkel Schetter，2010）和心理困扰量表（Brief Symptom Inventory；Derogatis & Spencer，1982）。在分析中控制了潜在的医疗和社会人口统计学混杂因素。
正如假设的那样，幸存者报告说，当他们得到更有效的伴侣支持时，他们的困扰会减少（p<0.001）。伴侣支持的数量与困扰无关（p=0.23）。交互作用表明，当伴侣支持有效时，幸存者收到的支持数量与他们的困扰无关（p=0.90）；然而，当伴侣支持无效时，收到更多的伴侣支持与显著升高的困扰有关（p=0.002）。
研究结果表明，针对 HSCT 后持久困扰的临床方法应该针对与伴侣支持的评估有效性相关的特征。
